Enhanced dissolution and bioavailability of grapefruit flavonoid Naringenin by solid dispersion utilizing fourth generation carrier

References

• Hollman PCH, Katan MB. Dietary flavonoids: intake, health effects and bioavailability. Food Chem Toxicol 1996;37:937–42
   Web of Science ®Google Scholar
• O’Reilly JD, Sanders TA, Wiseman H. Flavonoids protect against oxidative damage to LDL in vitro: use in selection of a flavonoid rich diet and relevance to LDL oxidation resistance ex vivo? Free Radic Res 2000;33:419–26
   PubMed Web of Science ®Google Scholar
• Scalbert A, Williamson G. Dietary intake and bioavailability of polyphenols. J. Nutr 2000;130:2073S–85S
   PubMed Web of Science ®Google Scholar
• Kanaze FI, Kokkalou E, Niopas I, et al. Dissolution enhancement of flavonoids by solid dispersions in PVP and PEG matrixes, a comparative study. J Appl Polym Sci 2006;102:460–71
   Web of Science ®Google Scholar
• Jayaraman J, Veerappan M, Namasivayam N. Potential beneficial effect of naringenin on lipid peroxidation and antioxidant status in rats with ethanol-induced hepatotoxicity. J Pharm Pharmacol 2009;61:1383–90
   PubMed Web of Science ®Google Scholar
• Rice-Evans CA, Miller NJ, Paganga G. Structure-antioxidant activity relationships of flavonoids and phenolic acids. Free Radic Biol Med 1996;20:933–56
   PubMed Web of Science ®Google Scholar
• Cao G, Sofic E, Prior RL. Antioxidant and prooxidant behavior of flavonoids: structure-activity relationships. Free Radic Biol Med 1997;22:749–60
   PubMed Web of Science ®Google Scholar
• Manthey JA. Biological properties of flavonoids pertaining to inflammation. Microcirculation 2000;7:S29–34
   PubMed Web of Science ®Google Scholar
• Goldwasser J, Cohen PY, Yang E, et al. Transcriptional regulation of human and rat hepatic lipid metabolism by the grapefruit flavonoid naringenin: role of PPARa, PPARc and LXRa. PLoS One 2010;5:e12399
   PubMed Web of Science ®Google Scholar
• Lee MH, Yoon S, Moon JO. The flavonoid naringenin inhibits dimethylnitrosamine induced liver damage in rats. Biol Pharm Bull 2004;27:72–6
   PubMed Web of Science ®Google Scholar
• Lee CH, Jeong TS, Choi YK, et al. Anti-atherogenic effect of citrus flavonoids, naringin and naringenin, associated with hepatic ACAT and aortic VCAM-1 and MCP-1 in high cholesterol-fed rabbits. Biochem Biophys Res Commun 2001;84:681–8
   Web of Science ®Google Scholar
• Madsen HL, Andersen CM, Jorgensen LV, Skibsted LH. Radical scavenging by dietary flavonoids. A kinetic study of antioxidant efficiencies. Eur Food Res Technol 2000;211:240–6
   Web of Science ®Google Scholar
• Yu J, Wang L, Walzem RL, et al. Antioxidant activity of citrus limonoids, flavonoids, and coumarins. J Agric Food Chem 2005;53:2009–14
   PubMed Web of Science ®Google Scholar
• Kanaze FI, Bounartzi MI, Georgarakis M, Niopas I. Pharmacokinetics of the citrus flavanone aglycones hesperetin and naringenin after single oral administration in human subjects. Eur J Clin Nutr 2007;61:472–7
   PubMed Web of Science ®Google Scholar
• Semalty A, Semalty M, Singh D, Rawat MSM. Preparation and characterization of phospholipid complexes of naringenin for effective drug delivery. J Incl Phenom Macrocycl Chem 2010;67:253–60
   Web of Science ®Google Scholar
• Suzuki H, Ogawa M, Hironaka K, et al. A nifedipine coground mixture with sodium deoxycholate. II. Dissolution characteristics and stability. Drug Dev Ind Pharm 2001;27:951–8
   PubMed Web of Science ®Google Scholar
• Aungst BJ. Novel formulation strategies for improving oral bioavailability of drugs with poor membrane permeation or presystemic metabolism. J Pharm Sci 1993;82:979–86
   PubMed Web of Science ®Google Scholar
• Ozdemir N, Erkin J. Enhancement of dissolution rate and bioavailability of sulfamethoxazole by complexation with β-cyclodextrin. Drug Dev Ind Pharm 2012;38:331–40
   PubMed Web of Science ®Google Scholar
• Devarajan PV, Sonavane GS. Preparation and in vitro/in vivo evaluation of gliclazide loaded Eudragit nanoparticles as a sustained release carriers. Drug Dev Ind Pharm 2007;33:101–11
   PubMed Web of Science ®Google Scholar
• Md S, Ali M, Baboota S, et al. Preparation, characterization, in vivo biodistribution and pharmacokinetic studies of donepezil-loaded PLGA nanoparticles for brain targeting. Drug Dev Ind Pharm 2014;40:278–87
   PubMed Web of Science ®Google Scholar
• Hussain A, Samad A, Nazish I, Ahmed FJ. Nanocarrier-based topical drug delivery for an antifungal drug. Drug Dev Ind Pharm 2014;40:527–41
   PubMed Web of Science ®Google Scholar
• Khan AW, Kotta S, Ansari SH, et al. Potentials and challenges in selfnanoemulsifying drug delivery systems. Expert Opin Drug Deliv 2012;9:1305–17
   PubMed Web of Science ®Google Scholar
• Craig DQ. The mechanisms of drug release from solid dispersions in water soluble polymers. Int J Pharm 2002;231:131–44
   PubMed Web of Science ®Google Scholar
• Damian F, Blaton N, Kinget R, Van den Mooter G. Physical stability of solid dispersions of the antiviral agent UC-781 with PEG 6000, Gelucire 44/14 and PVP K30. Int J Pharm 2002;244:87–98
   PubMed Web of Science ®Google Scholar
• Mooter GVD, Augustijns P, Blaton N, Kinget R. Physico-chemical characterization of solid dispersions of temazepam with polyethylene glycol 6000 and PVP K30. Int J Pharm 1998;164:67–80
   Web of Science ®Google Scholar
• Law D, Krill SL, Schmitt EA, et al. Physicochemical considerations in the preparation of amorphous ritonavir-poly (ethylene glycol) 8000 solid dispersions. J Pharm Sci 2000;90:1015–25
   Web of Science ®Google Scholar
• Hancock BC, Zografi G. Characteristics and significance of the amorphous state in pharmaceutical systems. J Pharm Sci 1997;86:1–12
   PubMed Web of Science ®Google Scholar
• Gowariker VR, Viswanathan NV, Sreedhar J. Polymer science. New Delhi: New Age; 1986:150–79
   Google Scholar
• Tommasini S, Raneri D, Ficarra R, et al. Improvement in solubility and dissolution rate of flavonoids by complexation with beta-cyclodextrin. J Pharm Biomed Anal 2004;35:379–87
   PubMed Web of Science ®Google Scholar
• Shulman M, Cohen M, Soto-Gutierrez A, et al. Enhancement of naringenin bioavailability by complexation with hydroxypropoyl-β-cyclodextrin. PLoS One 2011;6:e18033
   PubMed Web of Science ®Google Scholar
• Kanaze FI, Kokkalou E, Niopas I, et al. Dissolution rate and stability study of flavanone aglycones, naringenin and hesperetin, by drug delivery systems based on polyvinylpyrrolidone (PVP) nanodispersions. Drug Dev Ind Pharm 2010;36:292–301
   PubMed Web of Science ®Google Scholar
• Shamma RN, Basha M. Soluplus(R): a novel polymeric solubilizer for optimization of Carvedilol solid dispersions: formulation design and effect of method of preparation. Powder Technol 2013;237:406–14
   Web of Science ®Google Scholar
• Nagy ZK, Balogh A, Vajna B, et al. Comparison of electrospun and extruded Soluplus®-based solid dosage forms of improved dissolution. J Pharm Sci 2012;101:322–32
   PubMed Web of Science ®Google Scholar
• Costa P, Sousa Lobo JM. Influence of dissolution medium agitation on release profiles of sustained-release tablets. Drug Dev Ind Pharm 2001;27:811–17
   PubMed Web of Science ®Google Scholar
• Brewster ME, Vandecruys R, Verreck G, Peeters J. Supersaturating drug delivery systems: effect of hydrophilic cyclodextrins and other excipients on the formation and stabilization of supersaturated drug solutions. Pharmazie 2008;63:217–20
   PubMed Web of Science ®Google Scholar
• Jaur J, Aggarwal G, Singh G, Rana AC. Improvement of drug solubility using solid dispersion. Int J Pharm Pharm Sci 2012;4:47–53
   Google Scholar
• Choudhary A, Rana AC, Aggarwal G, et al. Development and characterization of an atorvastatin solid dispersion formulation using skimmed milk for improved oral bioavailability. Acta Pharm Sin B 2012;2:421–8
   Google Scholar
• Sethia S, Squillante E. Solid dispersion of carbamazepine in PVP K30 by conventional solvent evaporation and supercritical methods. Int J Pharm 2004;272:1–10
   PubMed Web of Science ®Google Scholar
• Linn M, Collnot EM, Djuric D, et al. Soluplus® as an effective absorption enhancer of poorly soluble drugs in vitro and in vivo. Eur J Pharm Sci 2012;45:336–43
   PubMed Web of Science ®Google Scholar
• Ma Y, Li P, Chen D, et al. LC/MS/MS quantitation assay for pharmacokinetics of naringenin and double peaks phenomenon in rats plasma. Int J Pharm 2006;307:292–9
   PubMed Web of Science ®Google Scholar
• Zhang Y, Wang J, Bai X, et al. Mesoporous silica nanoparticles for increasing the oral bioavailability and permeation of poorly water soluble drugs. Mol Pharm 2012;9:505–13
   PubMed Web of Science ®Google Scholar